Abstract
We present the first case of ovarian endometrioid carcinoma and endometriosis in a postmenopausal patient who was treated with tamoxifen for breast cancer. The association with prolonged unopposed estrogen-like stimulation with tamoxifen as a possible factor in the development of ovarian endometrioid carcinoma is discussed.
MeSH terms
-
Aged
-
Breast Neoplasms / drug therapy*
-
Carcinoma, Endometrioid / chemically induced*
-
Carcinoma, Endometrioid / pathology
-
Endometriosis / chemically induced*
-
Endometriosis / pathology
-
Female
-
Humans
-
Neoplasms, Second Primary / chemically induced*
-
Ovarian Neoplasms / chemically induced*
-
Ovarian Neoplasms / pathology
-
Postmenopause*
-
Tamoxifen / adverse effects*